News - Appointments

Ferdinand Verdonck joins Affimed Therapeutics

Read more

Ken Haas becomes partner at Abingworth

Read more

Bernhard Ehmer to become CEO at Biotest

Read more

Paul Workman appointed as advisor to Nuevolution

Read more

Eugen Leo to head clinical development at Oxford BioTherapeutics

Read more

Bryan Grenfell to join the Wellcome Trust

Read more

Erich Enghofer joins 4SC

Read more

Pam Liversidge joins Source BioScience

Read more

Olav Hellebø elected to board of Pharmalink

Read more

Børge Sørvoll joins Biotec Pharmacon

Read more